By Paul R. Ortiz de Montellano
This authoritative Fourth version summarizes the advances of the previous decade about the constitution, mechanism, and biochemistry of cytochrome P450 enzymes, with enough assurance of previous paintings to make each one bankruptcy a complete assessment of the sphere. 13 chapters are divided into designated volumes, the 1st overlaying the basics of cytochrome P450 biochemistry, in addition to the microbial, plant, and bug structures, and the second one completely targeting mammalian systems.
Volume 1 starts with an exploration of the biophysics and mechanistic enzymology of cytochrome P450 enzymes, with a dialogue of the constructions of P450 enzymes and their electron donor companions, the mechanisms of oxygen activation and substrate oxidation, and the ways and nature of cytochrome P450 inhibition. extra chapters speak about the character and roles of cytochrome P450 enzymes in microbes, vegetation and bugs, and an 8th bankruptcy is a survey of the aptitude application of P450 enzymes in biotechnology. the 1st bankruptcy of quantity 2 examines the jobs of P450 enzymes in mammals, quite often people. 4 extra chapters then take care of the genetic and hormonal legislation of P450 enzymes and their particular roles within the processing of sterols and lipids. Cytochrome P450: constitution, Mechanism, and Biochemistry is a key source for scientists, professors, and scholars drawn to fields as various as biochemistry, chemistry, biophysics, molecular biology, pharmacology and toxicology.
Read or Download Cytochrome P450: Structure, Mechanism, and Biochemistry PDF
Similar pharmacy books
Unfastened power calculations signify the main exact computational process to be had for predicting enzyme inhibitor binding affinities. Advances in laptop strength within the Nineteen Nineties enabled the sensible program of those calculations in cause drug layout. This ebook represents the 1st accomplished evaluation of this turning out to be region of study and covers the fundamental conception underlying the tactic, quite a few cutting-edge thoughts designed to enhance throughput and dozen examples in which unfastened power calculations have been used to layout and overview capability drug applicants.
The varsity of Pharmacy, college of London: medicinal drugs, technology and Society, 1842-2012 represents the wealthy background of the collage of London tuition of Pharmacy via a number of colour photos, vital advances within the pharmacy occupation, cultural milestones, biographies and extra. Written in an enticing and authoritative kind, this booklet depicts the chronological historical past of the varsity from its institution in 1842 to the current day with a nod towards its aspirations for the long run.
This quantity presents the reader with contemporary advances within the fields of molecular toxinology, the biotechnological purposes of venom pollutants, and antivenom construction. The content material of the twenty chapters of Venom Genomics and Proteomics illustrates not just the large development made because the implementation of omics applied sciences within the box of toxinology, yet one additionally realizes the line nonetheless forward to arrive a holistic view of venomous structures.
Targeting clinical and sensible points of method scale-up, this source information the idea and perform of moving pharmaceutical techniques from laboratory scale to the pilot plant and creation scale. It covers parenteral and nonparenterel drinks and semi-solids, items derived from biotechnology, dry mixing and powder dealing with, granulation and drying, fluid mattress functions, compaction and tableting, and picture coating and regulatory specifications for scale-up and postapproval alterations.
Extra info for Cytochrome P450: Structure, Mechanism, and Biochemistry
F. Johnson these ion pairs are broken, which frees Asp251 to serve its proposed role in shuttling protons from bulk solvent into the active site It thus appears that an important part of Pdx binding may be to “arm” the proton delivery machinery required for proton-coupled electron transfer The next obvious question is whether or not this sort of redox partner-mediated conformational change required for activity is a general property of all P450s or is limited to P450cam The weight of the evidence so far indicates that P450cam may be an outlier A number of P450s are known to be supported by nonphysiological redox partners and some redox partners, such as P450 reductase, service a large number of P450s The only structural comparisons that can be made to address this question are the P450cam–Pdx and CYP11A1–Adx complexes  CYP11A1 does not change to the open form in the complex but remains closed [69, 70] However, Asp290 (corresponds to Asp251 in P450cam) is not tied up in ion pairs and is exposed to bulk solvent Hence, no structural changes are required to free Asp290 for catalysis, although it has yet to be established if Asp290 is essential for CYP11A1 catalysis Given that Nature has so many P450s, it is doubtful that P450cam is the only P450 where selective redox partner binding coupled with conformational selection is required for activity It should only be a matter of time before similar P450s are uncovered and analyzed in depth Just as interesting a question is the biological basis for such control What is the evolutionary advantage, if any, of P450cam exhibiting such specificity, while very closely related P450s do not?
Poulos and E. F. Johnson drogen-specific active site J Steroid Biochem Mol Biol 118:197–202 106 Zhao B, Lei L, Kagawa N, Sundaramoorthy M, Banerjee S, Nagy LD, Guengerich FP, Waterman MR (2012) Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants J Biol Chem 287:10613–10622 107 DeVore NM, Scott EE (2012) Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 Nature 482:116–119 108 Strushkevich N, Usanov SA, Park HW (2010) Structural basis of human CYP51 inhibition by antifungal azoles J Mol Biol 397:1067–1078 109 Lepesheva GI, Hargrove TY, Anderson S, Kleshchenko Y, Furtak V, Wawrzak Z, Villalta F, Waterman MR (2010) Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi J Biol Chem 285:25582–25590 110 Walsh AA, Szklarz GD, Scott EE (2013) Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism J Biol Chem 288:12932–12943 111 Wang A, Savas U, Stout CD, Johnson EF (2011) Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1 J Biol Chem 286:5736–5743 112 Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 205-Å resolution J Biol Chem 279:38091–38094 113 Ekroos M, Sjogren T (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4 Proc Natl Acad Sci U S A 103:13682–13687 114 Porubsky PR, Meneely KM, Scott EE (2008) Structures of human cytochrome P450 2E1: insights into the binding of inhibitors and both small molecular weight and fatty acid substrates J Biol Chem 283:33698–33707 115 Porubsky PR, Battaile KP, Scott EE (2010) Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode J Biol Chem 285:22282–22290 116 Yano JK, Hsu MH, Griffin KJ, Stout CD, Johnson EF (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen Nat Struct Mol Biol 12:822–823 117 Smith BD, Sanders JL, Porubsky PR, Lushington GH, Stout CD, Scott EE (2007) Structure of the human lung cytochrome P450 2A13 J Biol Chem 282:17306–17313 118 Williams PA, Cosme J, Ward A, Angove HC, Matak VD, Jhoti H (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin Nature 424:464–468 119 Wester MR, Yano JK, Schoch GA, Yang C, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human microsomal cytochrome P450 2C9 com- 1 Structures of Cytochrome P450 Enzymes plexed with flurbiprofen at 20 Å resolution J Biol Chem 279:35630–35637 120 Reynald RL, Sansen S, Stout CD, Johnson EF (2012) Structural characterization of human cytochrome P450 2C19: active site differences between P450’s 2C8, 2C9 and 2C19 J Biol Chem 287:44581–44591 121 Wang A, Savas U, Hsu MH, Stout CD, Johnson EF (2012) Crystal structure of human cytochrome P450 2D6 with prinomastat bound J Biol Chem 287:10834–10843 122 Sevrioukova IF, Li H, Zhang H, Peterson JA, Poulos TL (1999) Structure of a cytochrome P450-redox partner electron-transfer complex Proc Natl Acad Sci U S A 96:1863–1868 123 Sevrioukova IF, Hazzard JT, Tollin G, Poulos TL (1999) The FMN to heme electron transfer in cytochrome P450BM-3 Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site J Biol Chem 274:36097–36106 124 Sevrioukova IF, Immoos CE, Poulos TL, Farmer P (2000) Electron transfer in the ruthenated heme domain of cytochrome P450BM-3 Isr J Chem 40:47–53 125 Adamovich TB, Pikuleva IA, Chashchin VL, Usanov SA (1989) Selective chemical modification of cytochrome P-450SCC lysine residues Identification of lysines involved in the interaction with adrenodoxin Biochim Biophys Acta 996:247–253 126 Coghlan VM, Vickery LE (1991) Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc J Biol Chem 266:18606–18612 127 Wada A, Waterman MR (1992) Identification by site-directed mutagenesis of two lysine residues in cholesterol side-chain cleavage cytochrome P450 that are essential for adrenodoxin binding J Biol Chem 267:22877–22882 128 Hiruma Y, Hass MA, Kikui Y, Liu WM, Olmez B, Skinner SP, Blok A, Kloosterman A, Koteishi H, Lohr F, Schwalbe H, Nojiri M, Ubbink M (2013) The structure of the cytochrome P450cam-putidaredoxin complex determined by paramagnetic NMR spectroscopy and crystallography J Mol Biol http:// wwwncbinlmnihgov/pubmed/23856620 129 Tripathi S, Li H, Poulos TL (2013) Structural basis for effector control and redox partner recognition in cytochrome P450 Science 340:1227–1230 130 Lipscomb JD, Sligar SG, Namtvedt MJ, Gunsalus IC (1976) Autooxidation and hydroxylation reactions of oxygenated cytochrome P-450cam J Biol Chem 251:1116–1124 131 Sligar SG, Debrunner PG, Lipscomb JD, Namtvedt MJ, Gunsalus IC (1974) A role of the putidaredoxin COOH-terminus in P-450cam (cytochrome m) hydroxylations Proc Natl Acad Sci U S A 71:3906– 3910 132 Tyson CA, Lipscomb JD, Gunsalus IC (1972) The role of putidaredoxin and P450 cam in methylene hydroxylation J Biol Chem 247:5777–5784 31 133 Pochapsky TC, Lyons TA, Kazanis S, Arakaki T, Ratnaswamy G (1996) A structure-based model for cytochrome P450cam-putidaredoxin interactions Biochimie 78:723–733 134 Geren L, Tuls J, O’Brien P, Millett F, Peterson JA (1986) The involvement of carboxylate groups of putidaredoxin in the reaction with putidaredoxin reductase J Biol Chem 261:15491–15495 135 Imai M, Shimada H, Watanabe Y, Matsushimahibiya Y, Makino R, Koga H, Horiuchi T, Ishimura Y (1989) Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine–a possible role of the hydroxy amino-acid in oxygen activation Proc Natl Acad Sci U S A 86:7823–7827 136 Kuznetsov VY, Poulos TL, Sevrioukova IF (2006) Putidaredoxin-to-cytochrome P450cam electron transfer: differences between the two reductive steps required for catalysis Biochemistry 45:11934– 11944 137 Unno M, Shimada H, Toba Y, Makino R, Ishimura Y (1996) Role of Arg112 of cytochrome P450cam in the electron transfer from reduced putidaredoxin Analyses with site-directed mutants J Biol Chem 271:17869–17874 138 Shimada H, Nagano S, Hori H, Ishimura Y (2001) Putidaredoxin-cytochrome P450cam interaction J Inorg Biochem 83:255–260 139 Unno M, Christian JF, Sjodin T, Benson DE, Macdonald ID, Sligar SG, Champion PM (2002) Complex formation of cytochrome P450cam with putidaredoxin Evidence for protein-specific interactions involving the proximal thiolate ligand J Biol Chem 277:2547–2553 140 Nagano S, Shimada H, Tarumi A, Hishiki T, KimataAriga Y, Egawa T, Suematsu M, Park SY, Adachi S, Shiro Y, Ishimura Y (2003) Infrared spectroscopic and mutational studies on putidaredoxin-induced conformational changes in ferrous CO-P450cam Biochemistry 42:14507–14514 141 Shiro Y, Iizuka T, Makino R, Ishimura Y, Morishima I (1989) N-15 NMR-Study on cyanide (C-15n-) complex of cytochrome-P-450cam–Effects of Dcamphor and putidaredoxin on the iron ligand structure J Am Chem Soc 111:7707–7711 142 Tosha T, Yoshioka S, Ishimori K, Morishima I (2004) L358P mutation on cytochrome P450cam simulates structural changes upon putidaredoxin binding: the structural changes trigger electron transfer to oxy-P450cam from electron donors J Biol Chem 279:42836–42843 143 Tosha T, Yoshioka S, Takahashi S, Ishimori K, Shimada H, Morishima I (2003) NMR study on the structural changes of cytochrome P450cam upon the complex formation with putidaredoxin Functional significance of the putidaredoxin-induced structural changes J Biol Chem 278:39809–39821 144 Pochapsky SS, Pochapsky TC, Wei JW (2003) A model for effector activity in a highly specific biological electron transfer complex: the cytochrome 32 P450(cam)-putidaredoxin couple Biochemistry 42:5649–5656 145 Zhang W, Pochapsky SS, Pochapsky TC, Jain NU (2008) Solution NMR structure of putidaredoxincytochrome P450cam complex via a combined residual dipolar coupling-spin labeling approach suggests a role for Trp106 of putidaredoxin in complex formation J Mol Biol 384:349–363 146 OuYang B, Pochapsky SS, Dang M, Pochapsky TC (2008) A functional proline switch in cytochrome P450cam Structure 16:916–923 147 Glascock MC, Ballou DP, Dawson JH (2005) Direct observation of a novel perturbed oxyferrous catalytic intermediate during reduced putidaredoxin-initiated turnover of cytochrome P-450-CAM: probing the effector role of putidaredoxin in catalysis J Biol Chem 280:42134–42141 148 Unno M, Christian JF, Benson DE, Gerber NC, SLigar SG, Champion PM (1997) Resonance Raman investigations of cytochrome P450cam complexed with putidaredoxin J Am Chem Soc 119:6614–6620 149 Davies MD, Qin L, Beck JL, Suslick KS, Koga H, Horiuchi T, Sligar SG (1990) Putidaredoxin reduction of cytochrome P-450cam–dependence of electron-transfer on the identity of putidaredoxins C-terminal amino-acid J Am Chem Soc 112:7396–7398 150 Davies MD, Sligar SG (1992) Genetic variants in the putidaredoxin-cytochrome P-450cam electrontransfer complex: identification of the residue responsible for redox-state-dependent conformers Biochemistry 31:11383–11389 T.
Johnson 151 Holden M, Mayhew M, Bunk D, Roitberg A, Vilker V (1997) Probing the interactions of putidaredoxin with redox partners in camphor P450 5-monooxygenase by mutagenesis of surface residues J Biol Chem 272:21720–21725 152 Pochapsky T, Lyons TA, Kazanis S, Arakaki T, Ratnaswamy G (1996) A structure-based model for cytochrome P450cam-putidaredoxin interactions Biochimie 78:723–733 153 Stayton PS, Sligar SG (1991) Structural microheterogeneity of a tryptophan residue required for efficient biological electron transfer between putidaredoxin and cytochrome P-450cam Biochemistry 30:1845–1851 154 Gerber NC, Sligar SG (1994) A role for Asp-251 in cytochrome P-450cam oxygen activation J Biol Chem 269:4260–4266 155 Stok JE, Yamada S, Farlow AJ, Slessor KE, De Voss JJ (2013) Cytochrome P450(cin) (CYP176A1) D241N: investigating the role of the conserved acid in the active site of cytochrome P450s Biochim Biophys Acta 1834:688–696 156 Bridges A, Gruenke L, Chang YT, Vakser IA, Loew G, Waskell L (1998) Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase J Biol Chem 273:17036–17049 157 Kleywegt GJ, Jones TA (1994) Detection, delineation, measurement and display of cavities in macromolecular structures Acta Crystallogr D Biol Crystallogr 50:178–185 2 Electron Transfer Partners of Cytochrome P450 Lucy Waskell and Jung-Ja P.